Paul T Quinlan sold $562K of Oruka Therapeutics (ORKA)

Executed Oct 20, disclosed Oct 21, the same day.

Value, as filed

$562K

7,100 sh across 2 lots

Executed

Oct 20

the trade date, as filed

Disclosed

Oct 21

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Paul T Quinlan General Counsel profile →

Paul T Quinlan (General Counsel) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $5.6M of ORKA (52,000 sh across 6 lots, as filed), executed Aug 14.

The name

ORKA

Oruka Therapeutics, Inc. ORKA · Healthcare · 32 filings in 24 months ticker →

Healthcare · Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psor…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Paul T Quinlan in ORKA

ORKASALE Oruka Therapeutics, Inc. $880K
9,399 sh across 3 lots
Exec Sep 21
Filed Sep 21 · 4:57 PM ET ORKASALE Oruka Therapeutics, Inc. $5.6M
52,000 sh across 6 lots
Exec Aug 14
Filed Aug 14 · 5:52 PM ET